ClinicalTrials.Veeva

Menu

Monocyte Activation in Preclinical Atherosclerosis (MAPA)

I

Institute for Atherosclerosis Research, Russia

Status

Completed

Conditions

Atherosclerosis

Treatments

Other: In vitro estimation of individual reactivity of monocytes

Study type

Observational

Funder types

Other

Identifiers

NCT02126280
IAR-MAPA

Details and patient eligibility

About

The study of proinflammatory and anti-inflammatory cytokines and chemokines expression profiles in human monocytes to identify new effective biomarkers that have the best diagnostic potential in asymptomatic atherosclerosis.

Full description

This project is the first step in creating a method for assessing an individual activity of macrophages. The problems addressed in the project are socially significant because of the high incidence of life-threatening diseases and their effects in the population. The method of evaluation of monocyte-macrophages activity in human blood will be based on the analysis of expression of cytokines and chemokines - markers of inflammatory and anti-inflammatory activity of macrophages. The most informative panel of cytokines and chemokines obtained during the project can be further used to create effective diagnostic tests.

Enrollment

170 patients

Sex

All

Ages

40 to 79 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • men and women aged 40 to 74 years
  • arterial normotension or mild arterial hypertension (systolic blood pressure <160 mm Hg, diastolic blood pressure <90 mm Hg)
  • absence of chronic diseases demanding permanent drug administration (more than 2 month per year)

Exclusion criteria

  • personal history of transient ischemic attacks
  • personal history of chronic diseases demanding permanent drug administration (more than 2 month per year)
  • personal history of life-threatening diseases
  • indications for surgical treatment of atherosclerotic lesions localized in the extracranial brachiocephalic system

Trial design

170 participants in 3 patient groups

Subclinical atherosclerosis
Description:
In vitro estimation of individual reactivity of monocytes in study participants with asymptomatic atherosclerotic plaques found in carotid arteries by ultrasound examination
Treatment:
Other: In vitro estimation of individual reactivity of monocytes
Healthy subjects
Description:
In vitro estimation of individual reactivity of monocytes in study participants without ultrasound signs of subclinical carotid atherosclerosis
Treatment:
Other: In vitro estimation of individual reactivity of monocytes
Diffuse intimal thickening
Description:
In vitro estimation of individual reactivity of monocytes in study participants with diffuse intima-media thickening of carotid arteries found at ultrasound examination
Treatment:
Other: In vitro estimation of individual reactivity of monocytes

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems